Market open
$
78.58
Change
-0.88 -1.11%
Volume
Volume 2.16m
Mar 21, 2023, 1:37 p.m.
Real time quotes
Previous close
$ 79.46
$ 78.58
Change
-0.88 -1.11%
Day low
Day high
$78.52
$80.05

52 week low
52 week high
$57.17
$89.74

Market cap
$99.09B
Average volume
6.51M
P/E ratio
21.60
Rev. per Employee
$1.59M
EPS
3.64
Dividend
0.75
Div yield
3.82%
Ex dividend date
3/14/23
MarketWatch News on GILD
-
Moderna Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Nurix’s stock rallies on Gilead’s option
- Jaimy Lee
-
Moderna Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Friday, outperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Moderna Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Moderna Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Moderna Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock rises Tuesday, outperforms market
- MarketWatch Automation
-
Moderna's Covid Boom Is Ending. Why the Outlook Isn't All Grim.
- Josh Nathan-Kazis
-
Moderna Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on GILD
-
First Drugs Facing Medicare Price Penalty Are Named
- Stephanie Armour
-
Seagen’s Cancer Therapy Is Making It a Takeover Target
- Jared S. Hopkins
-
Guild Esports launches Guild Studios
- TheNewswire.ca
-
- Edgar Online - (EDG = 10Q, 10K)
-
AQR CAPITAL MANAGEMENT LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
VALUEWORKS LLC Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of HealthInvest Partners AB
- GuruFocus.com
-
Top 5 4th Quarter Trades of Nan Shan Life Insurance Co., Ltd.
- GuruFocus.com
-
Top 5 4th Quarter Trades of Avalon Investment & Advisory
- GuruFocus.com
-
Caxton Associates Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
John Rogers Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
This Top Dividend Stock Just Hiked Its Payouts Again
- Baystreet.ca
-
GLOBEFLEX CAPITAL L P Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of KLCM Advisors, Inc.
- GuruFocus.com
-
Goodman Financial CORP Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of SECTOR GAMMA AS
- GuruFocus.com
-
Top 5 4th Quarter Trades of VAN ECK ASSOCIATES CORP
- GuruFocus.com
- Loading more headlines...
Press Releases on GILD
-
Gilead Sciences $GILD Investment Analysis and Advice
- Stock Traders Daily
-
Gilead Sciences $GILD Technical Pivots with Risk Controls
- Stock Traders Daily
-
Guild Esports launches Guild Studios
- TheNewswire.ca
-
Gilead Sciences (GILD) Trading Report
- Stock Traders Daily
-
Kite Completes Acquisition of Tmunity
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com